Condition
Primary Sjogren' clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Primary Sjogren' clinical trials that are recruiting, in China. By phase: Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Primary Sjogren' clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BCMA/CD70-directed CAR-T for children with hard-to-treat rheumatic diseases | Phase 1 | Hangzhou, Zhejiang | Recruiting | Sep 19, 2025 |
| OL-CD19-GDT CAR‑T for relapsed or refractory systemic sclerosis and primary Sjögren's syndrome | Phase 1 | Beijing | Recruiting | Sep 11, 2025 |
| Umbilical cord blood CD19-BCMA CAR T cell treatment for refractory lupus nephritis, systemic sclerosis, and Sjögren's with pulmonary hypertension | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Apr 27, 2025 |
| CD19-BCMA CAR T cell therapy for difficult-to-treat autoimmune diseases | Phase 1/2 | Beijing, China,Beijing | Recruiting | Apr 27, 2025 |
All recruiting trials (4)
-
BCMA/CD70-directed CAR-T for children with hard-to-treat rheumatic diseases
This trial will try a BCMA/CD70-directed CAR-T therapy in children aged 5 and older whose rheumatic diseases have not responded to standard treatments.
-
OL-CD19-GDT CAR‑T for relapsed or refractory systemic sclerosis and primary Sjögren's syndrome
This trial will try the CAR‑T therapy OL‑CD19‑GDT in adults whose systemic sclerosis or primary Sjögren's syndrome has relapsed or not responded to other treatments to see if it is safe and helps.
-
Umbilical cord blood CD19-BCMA CAR T cell treatment for refractory lupus nephritis, systemic sclerosis, and Sjögren's with pulmonary hypertension
This treatment will try umbilical cord blood–derived CD19‑BCMA CAR T cells in people with refractory lupus nephritis, systemic sclerosis, or primary Sjögren's syndrome with pulmonary hypertension who have not responded to standard therapies.
-
CD19-BCMA CAR T cell therapy for difficult-to-treat autoimmune diseases
This study is testing a new CAR T cell therapy to see if it can help people with tough autoimmune diseases like lupus nephritis, systemic sclerosis, and Sjogren's syndrome who haven't found relief with regular treatments.
Related topics
Quick answers
How many Primary Sjogren' clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.